Best OTC Hearing Aids for Seniors - 7-Platform AI Consensus Index

Answer Capsule

The consensus leader for over-the-counter hearing assistance is the Audien ION Pro 2, named by six of seven AI platforms (85.7% share) with an average listed rank of 5.7 and a best rank of 4. The strongest alternatives for distinct buyer needs are the Jabra Enhance Select 700 for seniors who want premium remote audiology support (71.4% share, average rank 1.4, best rank 1), the Lexie B2 Plus for independently lab-tested sound quality (42.9% share, average rank 2.3), and the Audicus Omni 2 for Bluetooth connectivity with remote adjustments (42.9% share, average rank 2.7). This study examined seven AI platforms—OpenAI, Anthropic, DeepSeek, Grok, Perplexity, Kimi, and Google—and identified 35 unique entities, of which 9 qualified by being named by at least two platforms. The principal limitation is that platform recommendations reflect each AI's retrieved sources, not independent product testing, and several entities face material corporate-stability or verification uncertainties.

Research Snapshot

The Consensus Ranking

Which Option Is Best for Which Version of the Buyer Need?

1. Audien ION Pro 2

Verdict: Audien ION Pro 2 is a good but not best-in-class fit for adults with perceived mild-to-moderate hearing loss seeking a rechargeable, behind-the-ear OTC hearing aid without a prescription or in-person fitting. Six of seven AI platforms named it during the ranking stage, with an average listed rank of 5.7 and a best rank of 4. The strongest reason to consider it is the combination of app-based sound customization, Bluetooth streaming, long claimed battery life, and a 45-day trial at a mid-range price. The main limitation is documented Bluetooth app instability and conflicting battery-life claims that reduce confidence for less tech-comfortable seniors.

Why it ranked here: Audien ION Pro 2 ranked first because it achieved the highest platform mention count (6 of 7 platforms, 85.7% share), despite a higher average listed rank of 5.7. The ranking methodology prioritizes platform mentions first, then average listed rank, then best listed rank.

Best suited for: Adults with perceived mild-to-moderate hearing loss who want to buy without a prescription or in-person fitting; tech-comfortable seniors who use iOS or Android smartphones; users who want Bluetooth phone calls, music streaming, directional microphones, and rechargeable operation; buyers prioritizing long battery life (48–72 hours claimed) and a 45-day trial.

Main strengths: App-based sound customization with six hearing profiles; Bluetooth streaming for phone calls and music; directional microphones; UV-sanitizing charging case; 45-day return window; 1-year manufacturer warranty; FSA/HSA eligible; phone support seven days a week from 7 a.m. to 4 p.m. Eastern Time.

Main limitations: Documented Bluetooth app instability requiring multiple reconnection attempts; conflicting battery-life claims (48 vs. 72 hours per charge); unverified FDA self-fitting clearance status; complete dependence on app control with limited physical button fallback; return process requires prior authorization and a phone consultation or video appointment.

Pricing or cost summary: New pair $689; open-box pair $539–$589; monthly protection plan $4/month; replacement deductible $169; additional Sound Check appointment $100; priority processing fee $9.00. DeepSeek reported a much lower $189 list price, but this appears to reference a different Audien model or outdated data.

Where platforms disagreed: Battery life claims conflicted (48 vs. 72 hours); app stability was disputed (Anthropic and Google documented significant connectivity issues, while OpenAI did not flag them); FDA regulatory status was unclear (Kimi and Perplexity could not verify 510(k) clearance); pricing varied across sources; fit ratings ranged from "good" (3 platforms) to "mixed" (2) to "uncertain" (2).

Audien ION Pro 2

2. Jabra Enhance Select 700

Verdict: Jabra Enhance Select 700 is a good-to-strong fit for adults with perceived mild-to-moderate hearing loss who want a premium OTC hearing aid with remote professional support. Five of seven AI platforms named it during the ranking stage, and it achieved an average listed rank of 1.4 with a best rank of 1. The strongest reason to consider it is the bundled package: three years of remote audiology care, a 100-day trial, a three-year warranty with loss-and-damage protection, and a discreet rechargeable receiver-in-canal design. The main limitation is price—$1,695 to $1,995 per pair—which exceeds the FDA-estimated OTC ceiling of under $1,500 and is significantly higher than budget OTC models.

Why it ranked here: Jabra Enhance Select 700 ranked second because it achieved the best average listed rank (1.4) and best rank (1) among all qualifying entities, but its platform mention count (5 of 7, 71.4%) was lower than Audien ION Pro 2's 6 mentions.

Best suited for: Seniors comfortable using a compatible iOS or Android smartphone; buyers who value professional remote audiology support; people who prioritize discretion and want the world's smallest rechargeable RIC design; buyers in noisy environments who want speech clarity features like Auto Focus; those who can afford $1,695–$1,995 and value included three-year audiology care and 100-day trial.

Main strengths: Three years of remote audiology services included; 100-day risk-free trial with free return shipping; three-year warranty with loss-and-damage protection ($195 deductible); Bluetooth LE Audio with Auracast broadcast capability; IP68 ingress protection; 24–30+ hours battery life per charge; discreet 2.12-gram RIC design.

Main limitations: Premium pricing above the FDA-estimated OTC ceiling; smartphone required for full functionality; no telecoil capability for hearing loops; sealed rechargeable battery with no disposable-battery fallback; remote-only care model; independent lab testing found speech-in-noise performance above average but not best-in-class for the price point.

Pricing or cost summary: Regular price $1,995 per pair; sale price $1,695; monthly financing $39–$65/month with 0% APR available; TV Streamer+ accessory $299; Multi Mic+ accessory $275; Upkeep Kit $39; loss-and-damage deductible $195.

Where platforms disagreed: Battery life figures conflicted (24, 24+, 30+, and up to 24 hours reported); speech-in-noise performance was debated (HearAdvisor rated B-grade with Auto Focus scoring 0.9/5 in initial-fit testing); pricing varied ($1,695, $1,795, $1,995); model availability was unclear (OpenAI flagged that Jabra's FAQ page lists Select 500, 300, and 50R as current models); Perplexity could not verify product-specific claims.

Jabra Enhance Select 700

3. Lexie B2 Plus

Verdict: Lexie B2 Plus is a conditional fit for over-the-counter hearing assistance as of August 2026. Three of seven platforms named it in the ranking stage, with an average listed rank of 2.33 and a best rank of 1. The strongest reason to consider it is its independently lab-tested sound performance—an A grade with a 4.5/5 SoundScore, ranked #4 among 63 OTC devices tested by HearAdvisor—combined with app-based self-fitting and a 45-day trial. The main limitation is a critical corporate stability risk: parent company LXE announced a U.S. operations wind-down in July 2026, with customer service guaranteed only through September 15, 2026.

Why it ranked here: Lexie B2 Plus ranked third based on its average listed rank of 2.33 and best rank of 1, with 3 platform mentions (42.9% share). Its strong average rank reflects high placement by DeepSeek (rank 1), OpenAI (rank 2), and Kimi (rank 4).

Best suited for: Seniors comfortable using a smartphone app or receiving remote assistance; buyers prioritizing rechargeable behind-the-ear devices with extensive sound customization; users wanting a 45-day direct-purchase trial and ongoing customer support; budget-conscious buyers seeking an alternative to prescription hearing aids priced at $4,000–$5,000.

Main strengths: HearAdvisor A grade with 4.5/5 SoundScore, ranked #4 among 63 OTC devices tested; app-based self-fitting with in-app hearing test; up to 18 hours battery per charge with charging case providing one additional full charge; Bluetooth phone call streaming from iOS and Android; 45-day direct-purchase trial; four environment programs and up to ten user-created programs.

Main limitations: Parent company LXE announced U.S. operations wind-down effective July 15, 2026, with customer service ending September 15, 2026; app longevity, warranty enforcement, and parts availability uncertain; pricing inconsistent across public pages ($899 vs. $999); the "3-year plan" could not be verified; music streaming not optimized; default receiver wire length may create pressure points.

Pricing or cost summary: Pair $899–$999 (varies by page/retailer); Lexie Club membership $9.99/month recurring; Protection Plus plan $72–$180 for 2-year accidental damage coverage; replacement fee under Club protection $360 per pair; replacement receiver wires $50; optional maintenance Care Kit $240.

Where platforms disagreed: Fit ratings ranged from strong (DeepSeek) to weak (Grok); the corporate wind-down was the dominant factor splitting opinions; pricing was inconsistent across Lexie's own pages; the "3-year plan" could not be verified; comfort findings were mixed regarding receiver wire length.

Lexie B2 Plus

4. Audicus Omni 2

Verdict: Audicus Omni 2 is a good fit for adults with perceived mild-to-moderate hearing loss seeking an over-the-counter hearing aid without an in-person prescription fitting. Five of seven AI research platforms rated it "good" for this use case; two rated it "uncertain" due to verification failures. Three platforms named it during the ranking stage, with an average listed rank of 2.67 and a best rank of 1. The strongest reason to consider it is its combination of independent lab-verified sound performance (HearAdvisor A-grade, top 11% of OTC devices tested), universal Bluetooth streaming, and remote audiology support. The main limitation is its premium pricing (approximately $1,898–$1,998 per pair) paired with a reported 16-hour rechargeable battery life.

Why it ranked here: Audicus Omni 2 ranked fourth with 3 platform mentions (42.9% share) and an average listed rank of 2.67. Grok ranked it first, Kimi ranked it third, and Perplexity ranked it fourth.

Best suited for: Seniors comfortable using a smartphone or receiving setup help remotely; buyers who prioritize Bluetooth streaming and hands-free calling on iPhone or Android; users wanting remote audiology adjustments without routine in-person visits; buyers who value a long trial period (100 days) and ongoing support more than the lowest purchase price.

Main strengths: HearAdvisor A-grade with SoundScore 4.32/5, ranked 8th of 61 OTC devices tested (top 11–13%); universal Bluetooth for iPhone and Android with hands-free calling; 16 channels of program customization with 6 listening environments; remote audiology support with lifetime access; 100-day money-back guarantee; two-year manufacturer warranty.

Main limitations: Premium pricing relative to OTC alternatives; reported 16-hour rechargeable battery life may not cover full days for heavy streamers; speech-in-noise performance limited in absolute terms (1.9/5); hybrid remote-fitting model requires pre-programming before shipment; return shipping costs not covered by company.

Pricing or cost summary: Omni 2 per pair (disposable battery) $1,898; rechargeable upgrade $50 per ear; rechargeable pair total $1,998; Audicus Premier subscription $119/month plus $249 setup fee; Premier loss replacement $150–$195 per hearing aid; Audicus Protect extended warranty $99 (single) or $198 (pair) for 36 months; optional remote control $299.

Where platforms disagreed: Rechargeable battery life conflicted (16 vs. 24 vs. 28 hours); return window discrepancy (45 vs. 100 days); pricing varied ($1,450, $1,498–$1,998, $1,898, $1,998); warranty duration conflicted (12 months vs. 2 years); two platforms (Kimi and Perplexity) could not verify the product due to official-site retrieval failures.

Audicus Omni 2

5. ELEHEAR

Verdict: ELEHEAR is a good fit for adults with perceived mild-to-moderate hearing loss seeking a prescription-free, app-customizable OTC hearing aid. Two of seven platforms (Google and OpenAI) named ELEHEAR during the ranking stage, with an average listed rank of 3.0. The strongest reason to consider it is its combination of independent lab-tested speech clarity performance—the Beyond Pro earned a 4.8/5 SoundScore and ranked #2 among 63 tested OTC aids—at a price well below prescription alternatives. The main limitation is smartphone dependency: full functionality requires an iOS 15+ or Android 8.0+ device.

Why it ranked here: ELEHEAR ranked fifth with 2 platform mentions (28.6% share) and an average listed rank of 3.0. Both Google and OpenAI ranked it third.

Best suited for: Tech-comfortable adults with mild-to-moderate hearing loss who can self-fit via smartphone app; budget-conscious buyers seeking advanced AI features at $399–$599 per pair; users prioritizing Bluetooth streaming, tinnitus masking, and real-time translation; seniors in rural areas with limited in-person audiologist access; buyers who want a 45-day trial.

Main strengths: Beyond Pro ranked #2 among 63 tested OTC aids with 4.8/5 SoundScore; speech in quiet scored 4.3/5 (1.66 points above average); speech in noise scored 3.6/5 (2.47 points above average); up to 20 hours battery per charge with charging case providing four additional full charges; 15-minute fast charge delivers approximately 6 hours of listening; tinnitus masking with 20+ soundscapes; 45-day risk-free trial.

Main limitations: Smartphone dependency with iOS 15+ or Android 8.0+ required; Consumer Reports found noise reduction weak and the model "not water resistant"; inconsistent official pricing ($509–$631 for Beyond Pro); post-trial warranty repairs require consumer-paid shipping even for manufacturer defects; customer support reported as "almost nonexistent via phone and email" in some independent reviews.

Pricing or cost summary: ELEHEAR Beyond $399 per pair; Beyond Pro $599–$649 depending on source; Beyond Pro plus dry-box bundle $631; optional Protection Plan ~$149; damage replacement deductible $200 per hearing aid, $180 per charging case; estimated annual accessories ~$93.

Where platforms disagreed: Noise reduction performance conflicted (Consumer Reports found weak noise reduction vs. HearAdvisor speech-in-noise score 3.6/5); battery life claims conflicted (20 vs. 24 vs. 15 hours); customer support quality disputed; water resistance disputed (IPX5 vs. no published IP rating); return policy discrepancy (45-day trial vs. 100-day return policy in Terms of Service).

ELEHEAR

6. Yeasound RIC800

Verdict: Yeasound RIC800 is a good fit for adults with perceived mild-to-moderate hearing loss seeking a lower-cost, self-fitting OTC hearing aid without an in-person prescription fitting. Two of seven AI platforms named it during the ranking stage, with an average listed rank of 4.5 and a best rank of 3. The strongest reason to consider it is its combination of top-tier independent lab performance (ranked #1 of 61 OTC devices by HearAdvisor with an A SoundGrade), 31-hour battery life, dual-platform Bluetooth streaming, and a generous 100-day advertised trial period. The main limitation is its preset-based fitting model—it lacks audiogram-based personalization and offers only 3–4 hearing-profile presets.

Why it ranked here: Yeasound RIC800 ranked sixth with 2 platform mentions (28.6% share) and an average listed rank of 4.5. Anthropic ranked it third; Kimi ranked it sixth.

Best suited for: Adults wanting a discreet receiver-in-canal design rather than an earbud-style OTC device; buyers who value rechargeable operation, Bluetooth calls and music on iOS and Android, and remote assistance; users comfortable selecting domes, pairing devices, and making basic app adjustments; price-sensitive buyers who can purchase during a verified promotion and use the 100-day trial.

Main strengths: HearAdvisor ranked #1 of 61 OTC devices tested with SoundScore 4.46/5 and A SoundGrade; HearingTracker awarded 4.2/5 overall and Expert Choice Award as 2025 Best OTC Hearing Aids; up to 31 hours battery per charge; dual-chip Bluetooth supporting iOS (MFi) and Android (ASHA) plus Auracast; IPX8 water resistance; 100-day advertised trial period; 12 channels.

Main limitations: Preset-based fitting with only 3–4 hearing-profile presets; no audiogram-based personalization; speech-in-noise performance mixed at 2.1/5 absolute terms; no true hands-free phone calling (users must speak into the phone receiver); app user reviews report slow loading and occasional failure to detect both hearing aids; telehealth support characterized as "limited" compared to competitors.

Pricing or cost summary: $529–$699 per pair depending on promotion and seller; DeepSeek reported $249 per pair (conflicting); Consumer Reports estimates approximately $48 annually for replacement accessories; replacement receiver wires $45 per unit; replacement wax guards approximately $18 per pack; replacement ear domes approximately $15 per set; optional installment financing from $63 per month.

Where platforms disagreed: Trial period discrepancy (100-day official vs. 45-day in Consumer Reports and product documentation); pricing ranged from $249 to $699; hearing test capability status (firmware update added app-based hearing test as of June 2026); telehealth support extent; Bluetooth hands-free calling capability; own-voice comfort; included accessories (four types and three sizes of ear domes vs. only one size).

Yeasound RIC800

7. Soundbright

Verdict: Soundbright Discovery is a good but conditional fit for U.S. adults with perceived mild-to-moderate hearing loss seeking an affordable, rechargeable OTC hearing aid without an in-person prescription fitting. Five of seven AI platforms rated it "good" or "mixed-good" for this use case, while two rated it "uncertain" due to limited independent verification. Two platforms named Soundbright in the ranking stage, with an average listed rank of 4.5 and a best rank of 4. The strongest reason to consider it is the combination of a low $249–$349 pair price, Bluetooth streaming, app-based controls, and a 45-day return window. The main limitation is documented customer service friction.

Why it ranked here: Soundbright ranked seventh with 2 platform mentions (28.6% share) and an average listed rank of 4.5. Google ranked it fourth; Kimi ranked it fifth.

Best suited for: Price-sensitive adults with mild-to-moderate hearing loss who want a rechargeable behind-the-ear OTC hearing aid without paying thousands of dollars; first-time OTC hearing aid users wanting app-based customization; users prioritizing conversation clarity in one-on-one settings; seniors comfortable with smartphone-based setup and troubleshooting; buyers who want a 45-day risk-free trial.

Main strengths: Low $249–$349 pair price; NCOA "Best for Conversations" designation with 5/5 tester rating for close conversations; six customizable hearing profiles; Bluetooth streaming for calls and music; app and physical-button controls; 45-day return window; stated 48-hour case-supported battery life; BBB A+ rating.

Main limitations: Documented customer service friction—difficulty reaching support by phone, email delays, and reported "ghosting" during returns; performs best in closer, quieter settings rather than noisy environments; battery life claims conflict (48 hours with case vs. ~17 hours single charge per Consumer Reports); Android users report Bluetooth connectivity stability issues; not water-resistant; limited independent evidence on comfort and long-term performance.

Pricing or cost summary: Discovery pair $249 (sale) / $349 (regular); alternate pricing $399 reported by DeepSeek; Discovery Care Kit (optional, 4-month supply) $39.99; 1-year accidental damage/loss Protection Plan $24.99; replacement accessories approximately $28/year; financing available through Affirm.

Where platforms disagreed: Fit ratings varied from "good" to "uncertain"; battery life claims conflicted (16, 17, 20, or 48 hours); customer service quality disputed (BBB A+ vs. Trustpilot complaints); self-fitting status unclear; app reliability varies by platform; pricing conflicts across sources; return shipping responsibility disputed.

Soundbright

8. Eargo 7

Verdict: Eargo 7 is a mixed-to-uncertain fit for adults seeking over-the-counter hearing assistance. Two of seven AI platforms (Anthropic and DeepSeek) named Eargo 7 during the ranking stage, giving it a 28.6% platform share with an average listed rank of 5.0. The strongest reason to consider it is its virtually invisible completely-in-canal (CIC) design combined with FDA-cleared self-fitting technology, rechargeable operation, and remote professional support. The main limitation is a critical one: LXE Hearing, Eargo's parent company, announced a wind-down of U.S. operations effective July 15, 2026, with customer support ending September 15, 2026.

Why it ranked here: Eargo 7 ranked eighth with 2 platform mentions (28.6% share) and an average listed rank of 5.0. Both Anthropic and DeepSeek ranked it fifth.

Best suited for: Adults with perceived mild-to-moderate hearing loss who prioritize near-invisible in-canal design; buyers who want rechargeable devices and are comfortable using a smartphone app; buyers who value access to remote hearing professionals without requiring an in-person prescription fitting; users who primarily need speech support in quiet or moderately challenging environments.

Main strengths: Virtually invisible CIC design with soft silicone petals; FDA-cleared self-fitting technology via Sound Match app; up to 16 hours battery per charge with charging case providing 2 additional full charges; IPX7 water resistance; 45-day return window; 2-year warranty with unlimited repairs and one-time loss/damage coverage; above-average speech-in-quiet performance.

Main limitations: Highest-priced OTC option at approximately $2,950 per pair; no Bluetooth audio streaming for music, TV, or phone calls; weak speech-in-noise performance (0.4–0.5/5 vs. 1.13 category average); LXE Hearing wind-down creates uncertainty about app functionality, warranty administration, and replacement parts; self-fitting process can be frustrating and inconsistent; CIC design requires specific insertion technique.

Pricing or cost summary: $2,950 per pair at full retail; often discounted to $2,490–$2,550; historical promotional pricing around $2,299; financing approximately $90–$96 per month; annual eartip replacements for related Eargo 8 approximately $360/year; Medicare and Medicaid do not cover OTC hearing aids.

Where platforms disagreed: Company operational status (Anthropic and Grok reported wind-down; DeepSeek's research predated it; Google did not mention it); speech-in-noise performance (HearAdvisor weak scores vs. company marketing emphasizing noise reduction); pricing varied ($2,299, $2,550, $2,650, $2,699, $2,950); fit ratings ranged from "good" to "weak"; charging case capacity conflicted (2 vs. 5 charges).

Eargo 7

9. Sennheiser All-Day Clear Slim

Verdict: Sennheiser All-Day Clear Slim is a mixed-to-good fit for U.S. adults with perceived mild-to-moderate hearing loss seeking an OTC hearing aid without a prescription fitting. Two of seven AI research platforms named it during the ranking stage (Google ranked it #2, Kimi ranked it #9), giving it a 28.6% platform share and an average listed rank of 5.5. The strongest reason to consider it is its combination of FDA-cleared OTC self-fitting, app-based customization, Bluetooth streaming, and a slim behind-the-ear design that independent reviewers found especially compatible with eyeglass wearers. The main limitation is significant uncertainty: the product appears to be end-of-life on Sennheiser's official U.S. site.

Why it ranked here: Sennheiser All-Day Clear Slim ranked ninth with 2 platform mentions (28.6% share) and an average listed rank of 5.5. Google ranked it second; Kimi ranked it ninth.

Best suited for: Adults comfortable completing setup and sound personalization through a smartphone app; users who want rechargeable hearing aids with hands-free calls and audio streaming; buyers who prefer a slim behind-the-ear body and an earbud-like receiver; eyeglass wearers who need a hearing aid that doesn't interfere with glasses frames; users who prioritize music and audio streaming quality.

Main strengths: FDA-cleared OTC self-fitting; intuitive app setup with guided hearing test; music streaming quality scored 3.8/5—a full 1.87 points above the OTC category average; perfect feedback control (5.0/5); slim design particularly good for eyeglass wearers; Bluetooth streaming and hands-free calls; 45-day return window for direct purchases; backed by Sonova, parent company of Phonak.

Main limitations: Product appears to be end-of-life on Sennheiser's official U.S. site; pricing claims range from $599.95 to $1,499; independent lab testing found weak speech-in-noise performance (1.0/5); Consumer Reports found failure to meet FDA amplification requirements for lower-pitched sounds; charging case lacks a built-in battery and must be plugged into a wall outlet; earbud-style tip causes occlusion.

Pricing or cost summary: Official U.S. page showed $599.95 but "not available" status; HearAdvisor lists $1,499; DeepSeek reported approximately $1,399; Kimi reported approximately $999.95; initial Slim MSRP was $1,499 with current All-Day Clear models at $949.95–$999.95; replacement Slim ear tips $11.95 for six; replacement Slim wax guards $11.95 for six; optional TV Connector accessory $349.95.

Where platforms disagreed: Availability status (end-of-life vs. still listed on retailer sites); pricing ranged from $599.95 to $1,499; battery life claims conflicted (16 vs. 21 vs. 24 hours); speech-in-noise performance (HearAdvisor 1.0/5 vs. Consumer Reports "good daily-use performance"); fit ratings ranged from "good" (3 platforms) to "mixed" (2) to "uncertain" (2).

Sennheiser All-Day Clear Slim

What the Cross-Platform Study Reveals About This Market

The OTC hearing aid market in 2026 is characterized by a wide price range—from approximately $249 per pair (Soundbright Discovery) to $2,950 per pair (Eargo 7)—with corresponding differences in service bundles, fitting models, and independent lab performance. The platforms consistently identified a trade-off between price and professional support: the most expensive options (Jabra Enhance Select 700 at $1,695–$1,995, Audicus Omni 2 at $1,898–$1,998, Eargo 7 at $2,950) bundle remote audiology services, longer warranties, and longer trial periods, while budget options (Soundbright at $249–$349, ELEHEAR at $399–$599) offer fewer support services and shorter warranties.

Independent laboratory testing emerged as a critical differentiator. HearAdvisor testing was cited across multiple entities: Yeasound RIC800 ranked #1 of 61 OTC devices tested (SoundScore 4.46/5), ELEHEAR Beyond Pro ranked #2 (SoundScore 4.8/5), Lexie B2 Plus ranked #4 (SoundScore 4.5/5), and Audicus Omni 2 ranked 8th (SoundScore 4.32/5). These lab results did not always correlate with platform ranking, suggesting that factors like brand recognition, pricing, and service bundles influenced platform recommendations more than raw acoustic performance.

Corporate stability emerged as a material risk factor in 2026. Two of the nine qualifying entities—Lexie B2 Plus and Eargo 7—share parent company LXE Hearing, which announced a U.S. operations wind-down effective July 15, 2026, with customer service ending September 15, 2026. This development materially affected platform fit ratings, with Grok rating both entities weakly and Anthropic rating both as uncertain.

Where the AI Platforms Agreed

OTC eligibility scope. All platforms agreed that OTC hearing aids are intended for adults 18 and older with perceived mild-to-moderate hearing loss and are not appropriate for severe or profound loss, consistent with FDA regulations.

Smartphone dependency. Platforms consistently noted that most OTC hearing aids require a compatible smartphone for full functionality, including app-based control, streaming, and remote adjustments. This was identified as a barrier for some seniors.

Rechargeable operation. All qualifying entities use rechargeable batteries, reflecting a market-wide shift away from disposable batteries. Battery life claims ranged from 16 hours (Audicus Omni 2, Eargo 7) to 31 hours (Yeasound RIC800).

Trial periods. Platforms consistently cited trial periods as important risk-reduction tools. The most common window was 45 days (Audien ION Pro 2, Lexie B2 Plus, ELEHEAR, Soundbright, Eargo 7, Sennheiser All-Day Clear Slim), with premium options offering 100 days (Jabra Enhance Select 700, Audicus Omni 2, Yeasound RIC800 advertised).

Independent lab testing as evidence. Platforms frequently cited HearAdvisor and Consumer Reports testing as key evidence for sound quality assessments, suggesting these independent sources carry significant weight in AI platform evaluations.

Remote audiology support as a differentiator. Platforms consistently identified remote audiology support as a distinguishing feature, with Jabra Enhance Select 700 (three years included), Audicus Omni 2 (lifetime support), and Lexie B2 Plus (Lexie Experts) receiving positive mentions.

Where the AI Platforms Disagreed

Corporate stability assessments. The most significant disagreement concerned Lexie B2 Plus and Eargo 7. DeepSeek, whose research predated the LXE wind-down announcement, rated both entities favorably. Anthropic and Grok, which accounted for the wind-down, rated them uncertain or weak. Google did not mention the wind-down for Eargo 7.

Battery life claims. Platforms reported conflicting battery life figures for nearly every entity: Audien ION Pro 2 (48 vs. 72 hours), Jabra Enhance Select 700 (24 vs. 30+ hours), Audicus Omni 2 (16 vs. 24 vs. 28 hours), ELEHEAR (20 vs. 24 vs. 15 hours), Soundbright (16 vs. 17 vs. 20 vs. 48 hours), and Sennheiser All-Day Clear Slim (16 vs. 21 vs. 24 hours).

Pricing. Pricing conflicts were documented for most entities, reflecting promotional pricing, open-box options, and outdated platform data. DeepSeek consistently reported lower prices than other platforms, likely reflecting older research dates.

Speech-in-noise performance. Platforms disagreed on noise reduction effectiveness, particularly for ELEHEAR (Consumer Reports found weak noise reduction vs. HearAdvisor scores 2.47 points above average) and Sennheiser All-Day Clear Slim (HearAdvisor 1.0/5 vs. Consumer Reports "good daily-use performance").

Verification failures. Perplexity and Kimi frequently could not verify product-specific claims due to retrieval failures, resulting in "uncertain" ratings that reflected evidence gaps rather than negative product assessments.

How Buyers Should Choose

Start by confirming the buyer's hearing loss is within the OTC mild-to-moderate range. FDA guidance states OTC hearing aids are not intended for severe or profound loss, and red-flag symptoms—sudden, one-sided, fluctuating, or painful hearing loss—require medical evaluation before any OTC purchase.

Determine whether the buyer can use a smartphone. All nine qualifying entities require a compatible iOS or Android device for full functionality. Buyers who cannot or will not use smartphone apps should consider preset-only models or seek alternatives with physical controls.

Establish a budget. The market spans $249–$2,950 per pair. Budget-focused buyers should evaluate Soundbright Discovery ($249–$349) and ELEHEAR ($399–$599). Buyers who value professional support should consider Jabra Enhance Select 700 ($1,695–$1,995) or Audicus Omni 2 ($1,898–$1,998).

Prioritize the trial period. All qualifying entities offer at least 45 days, with Jabra Enhance Select 700, Audicus Omni 2, and Yeasound RIC800 offering 100 days. Buyers should use the trial period to verify comfort, app reliability, and speech benefit in their typical listening environments.

Verify current corporate stability. As of August 2026, Lexie B2 Plus and Eargo 7 face parent-company wind-down uncertainty. Buyers considering these entities should verify current availability, support terms, and post-September 15, 2026 plans before purchasing.

Check independent lab results. HearAdvisor and Consumer Reports testing provide objective sound quality data. Buyers with significant hearing difficulty in noisy environments should prioritize entities with stronger speech-in-noise scores.

Confirm return shipping and restocking terms. Several entities require customer-paid return shipping, prior authorization, or phone consultations. These terms should be verified at checkout.

Methodology

This study used one standardized prompt sent once to each of seven AI platforms: OpenAI, Anthropic, DeepSeek, Grok, Perplexity, Kimi, and Google. Each platform evaluated entities against eight category criteria: self-fitting ease, app setup quality, sound customization, return window, rechargeable battery life, comfort, price, and customer support access.

The research date is 2026-08-13. Platform-reported research dates varied: DeepSeek reported dates ranging from 2026-02-04 to 2026-04-15 depending on the entity, while all other platforms reported 2026-08-13. These date discrepancies are disclosed as methodology limitations.

Entities qualified for the final ranking by being named by at least two platforms during the ranking discovery stage. The final ranking was calculated using platform mentions first, then average listed rank, then best listed rank. Platform mentions count only platforms that named the entity during ranking discovery; all seven platforms provided fit assessments for each entity.

The study drew on 235 deduplicated citations across 9 completed fit reviews. Sources were categorized as company-owned, independent, government, or unclear. Company-owned sources include official product pages, return policies, and warranty terms. Independent sources include Consumer Reports, HearAdvisor, HearingTracker, NCOA, and other review publications.

Methodology Limitations

Platform recommendations are not independent verification. AI platform responses reflect what each platform found in its retrieved sources, not independent product testing or customer experience. Platform agreement does not prove product quality.

Company-owned citations materially outnumber independent citations for some entities. For Audien ION Pro 2, 18 of 34 deduplicated sources were company-owned. Company claims should not be treated as independently verified.

Platform-reported research dates differ. DeepSeek reported research dates ranging from 2026-02-04 to 2026-04-15, approximately four to six months before the authoritative run date of 2026-08-13. DeepSeek's pricing and availability data may be stale.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Some URLs are Google grounding-api redirects rather than direct source URLs.

Conflicting product information was not resolved by guessing. Battery life, pricing, return windows, and warranty durations conflicted across sources for most entities. These conflicts are described rather than resolved.

Verification failures affected some platform ratings. Perplexity and Kimi frequently could not verify product-specific claims due to retrieval failures, resulting in "uncertain" ratings based on insufficient evidence rather than negative findings.

No personal testing was conducted. This study does not include personal testing, customer experience, or independent verification beyond the cited sources.

Corporate wind-down situations are time-sensitive. The LXE Hearing wind-down (affecting Lexie B2 Plus and Eargo 7) was announced July 15, 2026, with customer service through September 15, 2026. This study reflects the situation as of the research date of 2026-08-13.

Final Verdict

The Audien ION Pro 2 is the consensus leader for over-the-counter hearing assistance based on platform mentions, named by 6 of 7 AI platforms. However, the strongest overall recommendation for most seniors is the Jabra Enhance Select 700, which achieved the best average listed rank (1.4) and best rank (1) among all qualifying entities, offering three years of remote audiology care, a 100-day trial, and a three-year warranty with loss-and-damage protection.

For budget-focused buyers, ELEHEAR Beyond Pro at $599 per pair offers the best combination of independent lab performance (ranked #2 among 63 tested OTC aids) and affordability. For buyers prioritizing conversation clarity in quiet settings at the lowest price, Soundbright Discovery at $249–$349 offers strong value with documented customer service limitations.

Buyers should exercise caution with Lexie B2 Plus and Eargo 7 due to the LXE Hearing wind-down, and with Sennheiser All-Day Clear Slim due to apparent end-of-life status. All buyers should verify current pricing, battery specifications, return terms, and corporate stability before purchasing, as platform-reported data contained material conflicts across most entities.

For a broader comparison of options in this category, see the senior technology directory.